JoVE Logo

Oturum Aç

17.9 : Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric repeat sequence and enables repetitive cell division; however, in adults, telomerase is active only in the cells that need to divide regularly.

Because telomerase is inactive in most human somatic cells, the length of the telomere decreases with every cell division. After a critical length, telomere shortening leads to permanent cell cycle arrest. This mechanism is assumed to protect against cancer development by limiting the abnormal proliferation of tumors; however, a rare mutation can activate telomerase, which reconstructs the telomere region, allowing the cells to proliferate. Thus, telomerase is a perfect target for specific anticancer therapy, as most cancer cells express telomerase while normal cells do not.

The relation between telomere length and tumor formation has been experimentally verified using oncogenic mice. Oncogenic mice are mouse models that have cancer-causing genes. When such oncogenic mice are crossed with telomerase-deficient mice that lack telomerase activity, the resultant progeny mice express shorter telomeres than the oncogenic parent. These progeny mice, when interbred, generate successive generations that have progressively shorter telomeres. The frequency of tumor formation is studied by treating the progeny mice with carcinogens at every generation. As per the results, the late generation mice with shorter telomeres exhibit a reduced frequency of tumor formation compared to the early generation mice that maintain longer telomeres. This proves that limiting the replicative capacity of cells suppresses tumor formation.

Etiketler

Replicative Cell SenescenceFinite Number Of Cell DivisionsTelomereRepetitive DNA SequencesProtective Cap On ChromosomesTelomeraseSomatic CellsTelomere ShorteningPermanent Cell Cycle ArrestCancer DevelopmentAnticancer TherapyTelomerase Expression In Cancer CellsTelomere Length And Tumor FormationOncogenic Mice

Bölümden 17:

article

Now Playing

17.9 : Replicative Cell Senescence

Hücre Çoğalması

3.6K Görüntüleme Sayısı

article

17.1 : Hücre Döngüsü Nedir?

Hücre Çoğalması

10.1K Görüntüleme Sayısı

article

17.2 : Interfaz

Hücre Çoğalması

4.4K Görüntüleme Sayısı

article

17.3 : Hücre Döngüsü Kontrol Sistemi

Hücre Çoğalması

11.9K Görüntüleme Sayısı

article

17.4 : Pozitif Regülatör Molekülleri

Hücre Çoğalması

5.3K Görüntüleme Sayısı

article

17.5 : Cdk aktivitesinin inhibisyonu

Hücre Çoğalması

4.6K Görüntüleme Sayısı

article

17.6 : S-CDK DNA Replikasyonunu Başlatır

Hücre Çoğalması

4.6K Görüntüleme Sayısı

article

17.7 : M-CDK Sürücüleri Mitozise Geçiş

Hücre Çoğalması

5.5K Görüntüleme Sayısı

article

17.8 : Mitojenler ve Hücre Döngüsü

Hücre Çoğalması

6.3K Görüntüleme Sayısı

article

17.10 : Anormal Proliferasyon

Hücre Çoğalması

4.4K Görüntüleme Sayısı

article

17.11 : Hücreler büyümeyi ve çoğalmayı koordine eder

Hücre Çoğalması

4.4K Görüntüleme Sayısı

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır